salicylideneaniline has been researched along with clioquinol in 1 studies
| Studies (salicylideneaniline) | Trials (salicylideneaniline) | Recent Studies (post-2010) (salicylideneaniline) | Studies (clioquinol) | Trials (clioquinol) | Recent Studies (post-2010) (clioquinol) |
|---|---|---|---|---|---|
| 23 | 0 | 15 | 1,060 | 59 | 218 |
| Protein | Taxonomy | salicylideneaniline (IC50) | clioquinol (IC50) |
|---|---|---|---|
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 5.79 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 9.8 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 5.6 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 4.7863 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, LY; Li, SY; Wang, XB | 1 |
1 other study(ies) available for salicylideneaniline and clioquinol
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cell Line, Tumor; Copper; Humans; Neuroprotective Agents; Reactive Oxygen Species; Resveratrol; Stilbenes | 2014 |